EUVIMEDEUVIMED entdecken
CrossrefInfokarte

HEAD AND NECK CARCINOMA STEM CELLS. DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC TARGETS

Petar Stankovic, Dušan Milisavljević, Tamara Stanković

Facta Universitatis. Series: Medicine and Biology · 2022

DOI: 10.22190/fumb161003004s ↗
AbstractBibliografische Angaben

Abstract

Head and neck carcinoma arise from the mucosal lining of the upper aerodigestive tract, affecting more than half a million people worldwide each year. Although cancer tissue has many heterogeneous cells with different phenotypes, only a subset of these cancer cells proliferate extensively and have the potential to give rise to all other tumor cells. They are named carcinoma stem cells (CSC). CSCs can persist in tumors and cause relapse and metastasis by producing a new tumor. Head and neck carcinoma stem cells (HNCSC) share a common CD44+ phenotype. What drives a normal stem cell into a malignant stem cell is insufficiently understood. Many regulating pathways were analyzed, such as:Receptor Tyrosine Kinases, Sonic Hedgehog, Notch, Wnt, and Bmi1. Also, the miRNA ratio or epigenetic alteration pattern is potential subject of further studies. This would enable better therapy and survival rate in HNSCC.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →